Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Equisine Moist - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Equisine Moist

Approved

STANDARD

Equisine Moist

Duopharma Trade Philippines Inc.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: e5075ac63f603cd6
Company: Duopharma Trade Philippines Inc.
Type: Standard

Approval Details

Approval Id: e5075ac63f603cd6
Drug Approval Philippines Name: Equisine Moist
Product Name: Equisine Moist
Registration Number: DR-XY41287
Brand Name: Equisine Moist
Generic Name: Hypromellose
Dosage Form: Ophthalmic Drops
Dosage Strength: 30mg
Manufacturer: Duopharma Trade Philippines Inc.
Importer: CCM International (Philippines) Inc.
Distributor: CCM International (Philippines) Inc.
Issuance Date: 26 July 2022
Expiry Date: 03 October 2027
Pharmacologic Category: Ophthalmologic Lubricant
Classification: Over-The-Counter (OTC)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

e5075ac63f603cd6

Type

Standard

Back to Philippines FDA Approvals